Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia

In Vivo

Volumn 22, Issue 4, 2008, Pages 525-528

  Ahmad, Rizwan ^a   Tripathi, Anil Kumar ^a   Tripathi, Payal ^a   Singh, Sushma ^a   Singh, Ranjana ^a   Singh, Raj Kumar ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Biomarkers; CML; Malondialdehyde; MDA; Oxidative stress; PC; Protein carbonyl

Indexed keywords

CARBONYL DERIVATIVE; HYDROXYUREA; IMATINIB; MALONALDEHYDE;

ADULT; ARTICLE; CANCER GROWTH; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE EXACERBATION; FOLLOW UP; HUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL;

EID: 48349127906     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nowell PC and Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497, 1960.
2. Kurzrock R, Kantarjian HM, Drucker BJ and Talpaz M: Philadelphia chromosome-positive leukemias: From basic mechanisms to molecular therapeutics. Ann Intern Med 138: 819-830, 2003.
3. Klaunig JE and Kemendulis LM: The role of oxidative stress in carcinogenesis. Ann Rev Pharmacol Toxicol 44: 239-267, 2004.
4. Suzuki YJ, Forman HJ and Sevanian A: Oxidants as stimulators of signal transduction. Free Rad Biol Med 22: 269-285, 1997.
5. Irshad M and Chaudhuri PS: Oxidant-antioxidant system: Role and significance in human body. Ind J Exp Biol 40: 1233-1239, 2002.
6. Galli F, Piroddi M, Annetti C, Aisa C, Floridi E and Floridi A: Oxidative stress and reactive oxygen species. Contrib Nephrol 149: 240-260, 2005.
7. Singh V, Ghalaut PS, Kharb S and Singh GP: Plasma concentrations of lipid peroxidation products in children with acute leukemia. Ind J Med Sci 55: 215-217, 2001.
8. Mellqvist UH, Hansson M, Brune M, Dahlgren C, Hermodsson S and Hellstrand K: Natural killer cell dysfunction and apoptosis induced by chronic myeloid leuklemia cells: Role of reactive oxygen species and regulation by histamine. Blood 96: 1961-1968, 2000.
9. Dalle-Donne I, Rossi R, Colombo R, Giustarini D and Milazani A: Biomarkers of oxidative stress in human disease. Clin Chem 52: 601-623, 2006.
10. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R and Milazani A: Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10: 389-406, 2006.
11. Diplock AT, Rice-Evans CA and Burdon RH: Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention? Cancer Res 54: 1952s-1956s, 1994.
12. Choi MA, Kim BS and Yu R: Serum antioxidative vitamin levels and lipid peroxidation in gastric carcinoma patients. Cancer Letter 136: 89-93, 1999.
13. Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S and Husain SA. Lipid peroxidation, flee radical production and antioxidant status in breast cancer. Breast Cancer Res and Treat 59: 163-170, 2000.
14. Ghalaut VS, Ghalaut PS and Singh S: lipid peroxidation in leukemia. J Asso Phys Ind 47: 403-405, 1999.
15. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H and Ohshima H: Nitrated and oxidized protein in smokers and lung cancer patients. Cancer Research 61: 778-784, 2001.
16. Rossner P Jr, Terry MB, Gammon MD, Agrawal M, Zhang FF, Ferris JS, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI and Santella RM: Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med 11: 1138-1148, 2007.
17. Yilmaz IA, Akçay T, Cakatay U, Telci A, Ataus S and Yalçin V: Relation between bladder and protein oxidation. Int Urol Nephrol 35: 345-350, 2003.
18. Giacomo CD, Acquaviva R, Lanteri R, Licata F, Licata A, and Vanella A: Nonproteic antioxidant status in plasma of subjects with colon cancer. Exp Biol Med 228: 525-528, 2003.
19. Draper HH and Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186: 421-431, 1990.
20. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S and Stadtman ER: Determination of carbonyl content of oxidatively modified proteins. Methods Enzymol 186: 464-478, 1990.
21. Lowry, OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagents. J Biol Chem 193: 265-275, 1951.
22. Feron VJ, Til HP, de Vrijer F, Woutersen RA, Cassee FR and van Bladeren PJ: Aldehyde: occurrence, carcinogenic potential mechanism of action and risk assessment. Mutation Research 259: 363-385, 1991.
23. Morabito F, Cristani M, Saija A, Stelitano C, Callea V, Tomaino A, Minciullo PL and Gangemi S: Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma. Mediators Inflam 13: 381-383, 2004.
24. Brown RE, Alade SL, Wu MC, Wu FM and Bowman WP: Lipid peroxidation and T-cell leukemia of childhood. Effect of indomethacin. Cancer 64: 2090-2095, 1989.
25. Stocks J, Offerman EL, Modell CB and Dormandy TL: The susceptibility to autooxidation of human red cell lipids in health and disease. Br J Hematol 23: 713-724, 1972.
26. Popadiuk S, Korzon M, Renke J and Wozniak M: Carbonyl group content on the basis of protein peroxidation analysis with total antioxidant status in blood of children with cancers. Wiad Lek 51: 107-112, 1998 (Article in Polish).
27. Renke J, Popadiuk S, Korzon M, Bugajczyk B and Wozniak M: Protein carbonyl groups content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Rad Biol Med 29: 101-104, 2000.
28. Mutlu-Türkoǧlu U, Akalin Z, Ilhan E, Yilmaz E, Bilge A, Nişanci Y and Uysal M: Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease. Clin Biochem 38: 1059-1065, 2005.
29. Slatter DA, Bolton CH and Bailey AJ: The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 43: 550-557, 2000.
30. Mutlu-Türkoǧlu U, Ilhan E, Oztezcan S, Kuru A, Aykaç-Toker G and Uysal M: Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 36: 397-400, 2003.